Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel
OTCMKTS:EKTAY

Elekta Q2 2026 Earnings Results & Report

Elekta logo
$6.23 +0.04 (+0.57%)
As of 11/11/2026 02:28 PM Eastern

Elekta missed analyst revenue expectations in its Q2 2026 results, released November 26, 2025. The company reported EPS of $0.07, while revenue of $427.85 million fell short of the $436.91 million estimate by $9.06 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date

Elekta EPS Results

Actual EPS
$0.07
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Elekta Revenue Results

Actual Revenue
$427.85 million
Expected Revenue
$436.91 million
Beat/Miss
Missed by -$9.06 million
YoY Revenue Growth
N/A

Upcoming Earnings

Elekta's next earnings date is estimated for Wednesday, November 25, 2026, based on past reporting schedules.

Conference Call Resources

Elekta Q2 2026 Earnings FAQ

Elekta (OTCMKTS:EKTAY) reported earnings of $0.07 per share for Q2 2026. The report was announced on Wednesday, November 26, 2025.

Elekta reported revenue of $427.85 million for Q2 2026, against a consensus estimate of $436.91 million.

Elekta's next earnings date is estimated for Wednesday, November 25, 2026. MarketBeat tracks confirmed and estimated earnings dates for Elekta on the company's earnings history page.

Elekta Earnings Headlines

Elekta Announces Second-Quarter 2026/27 Results Presentation
November 11 at 3:11 AM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-announces-second-quarter-2026-27-results-presentation?utm_source=marketbeat.com&utm_medium=referral
Elekta (EKTAY) & Its Competitors Critical Contrast
November 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31170933
55+? Elon’s Gift…
James Altucher points to Elon Musk's latest FCC filing as a potential turning point for retirees relying on Social Security. While seniors are getting a raise of about $75 a month, SpaceX turned 4,400 people into millionaires overnight, and Tesla created so many that the press coined the term 'Teslanaires.' By Altucher's estimates, Musk has created around 100,000 millionaires so far. He believes this filing could produce 1.8 million more.tc pixel
November 12 at 1:00 AM  |  Paradigm Press (Ad)
Elekta names investor-led Nomination Committee ahead of 2027 AGM
October 30, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-names-investor-led-nomination-committee-ahead-of-2027-agm?utm_source=marketbeat.com&utm_medium=referral
Elekta data support expanded use of Gamma Knife for multiple brain metastases
September 29, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elekta-data-support-expanded-use-of-gamma-knife-for-multiple-brain-metastases?utm_source=marketbeat.com&utm_medium=referral
Elekta’s Unity Data Boost Pancreatic Cancer Outcomes as Unity Pro Rolls Out
September 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/elektas-unity-data-boost-pancreatic-cancer-outcomes-as-unity-pro-rolls-out?utm_source=marketbeat.com&utm_medium=referral
See More Elekta Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Elekta? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elekta and other key companies, straight to your email.

About Elekta

Elekta (OTCMKTS:EKTAY) is a Swedish medical technology company that develops equipment and software for radiation therapy and other treatments used in cancer care and neurosurgery. Founded in 1972 by neurosurgeon Lars Leksell, the company builds on his work in stereotactic radiosurgery.

Its offerings include linear accelerators for external-beam radiation therapy, systems for stereotactic radiosurgery and brachytherapy, and software that helps healthcare providers plan and manage treatment. Elekta’s technologies are used by hospitals and clinics to deliver care for cancer and certain neurological conditions.

The company serves healthcare providers in markets around the world. Its work spans equipment, treatment-planning tools, and clinical information systems designed to support radiation oncology services.

View Elekta Profile
Earnings Tools